Patients who have undergone chemo-radiotherapy and/or tumor removal have the lower frequency of EGFR mutations in tumor tissue (41.0%) and plasma (25.0%) compared to others (60.8%, P = 0.028; and 52.2%, P = 0.002, respectively, Additional file 2: Table S2). The gene discussed is EGFR; the disease is neoplasm.